肺炎衣原体（衣原体属TWAR株）的体外药敏试验
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).
作者信息
Chirgwin K, Roblin P M, Hammerschlag M R
机构信息
Department of Medicine, State University of New York Health Science Center, Brooklyn 11203.
出版信息
Antimicrob Agents Chemother. 1989 Sep;33(9):1634-5. doi: 10.1128/AAC.33.9.1634.
Abstract
The in vitro susceptibilities of two clinical isolates of Chlamydia pneumoniae from Brooklyn, N.Y., were determined for tetracycline, erythromycin, sulfamethoxazole, ciprofloxacin, and three new macrolides--azithromycin, clarithromycin, and roxithromycin. Clarithromycin was the most active drug tested, followed by the other macrolides, tetracycline, and ciprofloxacin.
摘要
测定了从纽约布鲁克林分离出的两株肺炎衣原体临床分离株对四环素、红霉素、磺胺甲恶唑、环丙沙星以及三种新型大环内酯类药物——阿奇霉素、克拉霉素和罗红霉素的体外敏感性。克拉霉素是所测试药物中活性最强的，其次是其他大环内酯类药物、四环素和环丙沙星。
相似文献
1
In vitro susceptibilities of Chlamydia pneumoniae (Chlamydia sp. strain TWAR).肺炎衣原体（衣原体属TWAR株）的体外药敏试验
Antimicrob Agents Chemother. 1989 Sep;33(9):1634-5. doi: 10.1128/AAC.33.9.1634.
2
The in-vitro activity of clarithromycin and other macrolides against the type strain of Chlamydia pneumoniae (TWAR).克拉霉素及其他大环内酯类药物对肺炎衣原体（TWAR）标准菌株的体外活性。
J Antimicrob Chemother. 1991 Feb;27 Suppl A:43-5. doi: 10.1093/jac/27.suppl_a.43.
3
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.阿奇霉素、克拉霉素、红霉素和四环素对13株肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1996 Jan;40(1):212-4. doi: 10.1128/AAC.40.1.212.
4
In vitro drug susceptibility of Chlamydia sp. strain TWAR.沙眼衣原体TWAR株的体外药物敏感性
Antimicrob Agents Chemother. 1988 Feb;32(2):257-8. doi: 10.1128/AAC.32.2.257.
5
Comparative in vitro activity of garenoxacin against Chlamydia spp.加替沙星对衣原体属的体外活性比较
J Antimicrob Chemother. 2002 Sep;50(3):407-10. doi: 10.1093/jac/dkf145.
6
In vitro evaluation of activities of azithromycin, erythromycin, and tetracycline against Chlamydia trachomatis and Chlamydia pneumoniae.阿奇霉素、红霉素和四环素对沙眼衣原体和肺炎衣原体活性的体外评估
Antimicrob Agents Chemother. 1992 Feb;36(2):291-4. doi: 10.1128/AAC.36.2.291.
7
[Detection and the antibiotic susceptibility analysis of mycoplasma and chlamydia in urogenital tract infections of 327 cases patients with tubal infertility].327例输卵管性不孕患者泌尿生殖道感染支原体和衣原体的检测及药敏分析
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi. 2011 Jun;25(3):201-4.
8
In vitro susceptibility of recent clinical isolates of Chlamydia trachomatis to macrolides and tetracyclines.沙眼衣原体近期临床分离株对大环内酯类和四环素类药物的体外敏感性
Diagn Microbiol Infect Dis. 2001 Mar;39(3):177-9. doi: 10.1016/s0732-8893(01)00221-8.
9
In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.新型抗菌酮内酯类药物塞曲霉素对肺炎衣原体的体外活性
J Antimicrob Chemother. 2003 Sep;52(3):497-9. doi: 10.1093/jac/dkg371. Epub 2003 Aug 13.
10
In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.阿奇霉素、克拉霉素及其他抗生素对肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1996 Nov;40(11):2669-70. doi: 10.1128/AAC.40.11.2669.
引用本文的文献
1
Antibiotics for secondary prevention of coronary heart disease.用于冠心病二级预防的抗生素。
Cochrane Database Syst Rev. 2021 Feb 23;2(2):CD003610. doi: 10.1002/14651858.CD003610.pub4.
2
Inhibitory activity of the isoflavone biochanin A on intracellular bacteria of genus Chlamydia and initial development of a buccal formulation.异黄酮染料木黄酮对衣原体属细胞内细菌的抑制活性及口腔制剂的初步研发
PLoS One. 2014 Dec 16;9(12):e115115. doi: 10.1371/journal.pone.0115115. eCollection 2014.
3
Antibiotic susceptibility of Waddlia chondrophila in Acanthamoeba castellanii amoebae.嗜软骨沃氏菌在卡氏棘阿米巴中对抗生素的敏感性
Antimicrob Agents Chemother. 2009 Jun;53(6):2663-6. doi: 10.1128/AAC.00046-09. Epub 2009 Mar 30.
4
Telithromycin treatment of chronic Chlamydia pneumoniae infection in C57BL/6J mice.替利霉素治疗C57BL/6J小鼠慢性肺炎衣原体感染
Antimicrob Agents Chemother. 2004 Oct;48(10):3655-61. doi: 10.1128/AAC.48.10.3655-3661.2004.
5
Antibiotic trials for coronary heart disease.冠心病的抗生素试验。
Tex Heart Inst J. 2004;31(1):33-8.
6
In vitro activity of a new 8-methoxyquinolone, BAY 12-8039, against Chlamydia pneumoniae.新型8-甲氧基喹诺酮BAY 12-8039对肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1998 Apr;42(4):951-2. doi: 10.1128/AAC.42.4.951.
7
In vitro activities of azithromycin, clarithromycin, erythromycin, and tetracycline against 13 strains of Chlamydia pneumoniae.阿奇霉素、克拉霉素、红霉素和四环素对13株肺炎衣原体的体外活性
Antimicrob Agents Chemother. 1996 Jan;40(1):212-4. doi: 10.1128/AAC.40.1.212.
8
In vitro and in vivo antichlamydial activities of newly developed quinolone antimicrobial agents.新开发的喹诺酮类抗菌剂的体外和体内抗衣原体活性。
Antimicrob Agents Chemother. 1993 Apr;37(4):801-3. doi: 10.1128/AAC.37.4.801.
9
Chlamydia pneumoniae.肺炎衣原体
Thorax. 1993 Jan;48(1):1-4. doi: 10.1136/thx.48.1.1.
10
In vitro activity of azithromycin (CP-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae.阿奇霉素（CP - 62,993）对沙眼衣原体和肺炎衣原体的体外活性。
Antimicrob Agents Chemother. 1993 Sep;37(9):1746-8. doi: 10.1128/AAC.37.9.1746.
本文引用的文献
1
An epidemic of mild pneumonia due to an unusual strain of Chlamydia psittaci.由一种不寻常的鹦鹉热衣原体菌株引起的轻度肺炎疫情。
J Infect Dis. 1985 May;151(5):832-9. doi: 10.1093/infdis/151.5.832.
2
A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections.一种新的鹦鹉热衣原体菌株，TWAR，在急性呼吸道感染中分离得到。
N Engl J Med. 1986 Jul 17;315(3):161-8. doi: 10.1056/NEJM198607173150305.
3
Pneumonia associated with the TWAR strain of Chlamydia.与衣原体TWAR菌株相关的肺炎
Ann Intern Med. 1987 Apr;106(4):507-11. doi: 10.7326/0003-4819-106-4-507.
4
In vitro susceptibilities of mycoplasmas and ureaplasmas to new macrolides and aryl-fluoroquinolones.支原体和脲原体对新型大环内酯类药物及芳基氟喹诺酮类药物的体外敏感性
Antimicrob Agents Chemother. 1988 Oct;32(10):1500-2. doi: 10.1128/AAC.32.10.1500.
5
In vitro drug susceptibility of Chlamydia sp. strain TWAR.沙眼衣原体TWAR株的体外药物敏感性
Antimicrob Agents Chemother. 1988 Feb;32(2):257-8. doi: 10.1128/AAC.32.2.257.
Zotero 插件